This month of May is ALS Awareness Month, and marks an opportune time to spotlight the disease and the importance of ...

STATEN ISLAND, N.Y. — Robert Moffit, a lifelong Staten Island resident who became an advocate for New York’s Medical Aid in ...

Late last year, the therapy developers dosed their first patient following positive preclinical data demonstrating safety and ...

Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an expanded access program (EAP) ...

Dr. Gomez brings extensive neuroscience and orphan disease development experience to Raya as it plans multiple clinical trials in 2026. MONTREAL, QUEBEC, CANADA, May 8, 2025 /EINPresswire.com/ -- Raya ...

Within a couple hours, the bride was doing the limbo under Eby’s walker, and Eby was giving people walker rides all over the ...

Golden said painless progressive weakness is the key to recognizing ALS, and although research still has a long way to go, ...

Coya Therapeutics, Inc.’s COYA share price has surged by 12.31%, which has investors questioning if this is right time to ...

The third patient of Elon Musk's brain computer interface company Neuralink is using Musk's AI chatbot Grok to speed up ...

The approved ALS therapy Radicava may cause serious unexpected side effects, such as liver problems and blood clots, per U.S.

Clene’s cash and cash equivalents totaled $9.8 million as of March 31, 2025, compared to $12.2 million as of December 31, 2024. Clene expects that its resources as of March 31, 2025, will be ...

The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.